CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −2,837.05 | 0 | ||
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −2,837.05 | 0 | ||
| 2024-01-02 | Singer Michael Director | Grant or award | +178,000 | 288,123 | ||
| 2024-01-02 | Singer Michael Director | Grant or award · Stock Option (Right to Buy) | +228,000 | 228,000 | ||
| 2023-12-22 | Singer Michael Director | Gift · Series A Convertible Preferred Stock | −3,000 | 3,304.56 | ||
| 2023-11-13 | Singer Michael Director | Grant or award | +110,123 | 110,123 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +197,663 | 197,663 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +29,212 | 29,212 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +3,670 | 3,670 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +49,555 | 49,555 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +49,555 | 49,555 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +7,616 | 7,616 | ||
| 2023-11-13 | Singer Michael Director | Grant or award · Series A Non-Voting Convertible Preferred Stock | +6,304.56 | 6,304.56 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +11,316.26 | 11,316.26 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +1,672.39 | 1,672.39 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +210.15 | 210.15 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +2,837.05 | 2,837.05 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +2,837.05 | 2,837.05 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +436.07 | 436.07 |
Page 2 of 2 · 39 trades